Ledger.Open graph →
SEC Form D · Amendment · filed September 17, 2020

Inhalon Biopharma, Inc

Offering
$3.6M
Sold
$2.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CARRBORO, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Samuel B. Lai · Carrboro, NCExec · DirectorWinnie B. Wan · Carrboro, NCDirectorJohn B. Whelan · Carrboro, NCExec · DirectorJaimin Gandhi · Columbus, OHDirectorDaniel Dahan · Thornhill, Ontario, CanadaExec · DirectorLuke Buchanan · Columbus, OHExec · DirectorAnthony Tomasello · Chicago, ILExec · DirectorJames Q. Mi · Grand Cayman, Cayman IslandsDirectorJohn E. Parker · Newtown, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗